Sunday, June 28, 2020 1:23:33 PM
dead and no more than 10 placebos were still alive at the time of interim analysis (March 2017).
My estimate of 8 placebos who are PFS beyond 36 months is a worse case scenario. If there were a maximum 8 such placebo patients, most of them may have originated from about 74 placebo patients who originated from the first 182 patients enrolled and who were no longer individually represented (censored) in the 2018 JTM publication.
Furthermore, it is hard for me to take literally the November 2018 SNO update when it implies that between March 2017 and about May? 2018, 12 of the 66 placebos (18.2%) who crossed over, progressed so late after their surgery. How many of the about 10 most recent placebos surviving at 3/17 had not yet crossed over and did so between 3/17 and let's say 5/18? How many of the approximately 74 surviving placebos who were at 3/17 on trial for more than 30 months, crossed over so late in the game? There may have been a few but it is hard to believe that a total of 12 placebos crossed over so late. I have always wondered whether there was such a massive late crossing over or perhaps a purposeful final approximation at the 2018 SNO update which gave us the 90% crossover figure.
Recent NWBO News
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM